These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16042656)

  • 1. Review article: gastro-oesophageal reflux disease--the health economic implications.
    Mason J; Hungin AP
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():20-31. PubMed ID: 16042656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease.
    Sridhar S; Huang J; O'Brien BJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):865-73. PubMed ID: 8971282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
    Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
    Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts.
    Toghanian S; Wahlqvist P; Johnson DA; Bolge SC; Liljas B
    Clin Drug Investig; 2010; 30(3):167-78. PubMed ID: 20155989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Remák E; Brown RE; Yuen C; Robinson A
    Curr Med Res Opin; 2005 Oct; 21(10):1505-17. PubMed ID: 16238890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease.
    Cookson R; Flood C; Koo B; Mahon D; Rhodes M
    Br J Surg; 2005 Jun; 92(6):700-6. PubMed ID: 15852426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.
    Inadomi JM
    Pharmacoeconomics; 2002; 20(9):565-76. PubMed ID: 12141885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF; Rey JF; Caekaert A; Barthélemy P
    Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
    Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
    Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden.
    Agréus L; Borgquist L
    Pharmacoeconomics; 2002; 20(5):347-55. PubMed ID: 11994044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity.
    Wahlqvist P; Reilly MC; Barkun A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):259-72. PubMed ID: 16842452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.